ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AX06 | B | Pomalidomide - 3mg | 11548 | 146621/1 | IMNOVID | 3mg | 21 | Capsule, hard | Oral | Droguerie de l'Union | Celgene International SARL | Switzerland | 10,865,805 L.L | 2.44 | E2 | Bristol-Myers Squibb Pharma EEIG | Ireland | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AX06 | B | Pomalidomide - 3mg | 10302 | 90820/1 | IMNOVID | 3mg | 21 | Capsule, hard | Oral | Droguerie de l'Union | Celgene International SARL | Switzerland | 10,865,805 L.L | 2.44 | E2 | Celgene Europe BV | The Netherlands | 2/5/2024 | |
L04AX06 | B | Pomalidomide - 3mg | 10302/945 | 90820/1 | IMNOVID | 3mg | 21 | Capsule, hard | Oral | Droguerie de l'Union | Celgene International SARL | Switzerland | 662,450,757 L.L | 2.44 | E2 | Celgene Europe BV | The Netherlands | 2/5/2024 | 0 |
L04AX06 | B | Pomalidomide - 3mg | 11548/945 | 146621/1 | IMNOVID | 3mg | 21 | Capsule, hard | Oral | Droguerie de l'Union | Celgene International SARL | Switzerland | 662,450,757 L.L | 2.44 | E2 | Bristol-Myers Squibb Pharma EEIG | Ireland | 2/5/2024 | 0 |